Disufenton sodium

$48$480

Products Details

Product Description

– Disufenton sodium (NXY-059) is a derivative of the neuroprotective agent phenylbutynitrone and has extremely strong free radical scavenging ability.

Web ID

– HY-13244

Storage Temperature

– 4°C (Powder, sealed storage, away from moisture)

Shipping

– Room Temperature

Applications

– Neuroscience-Neurodegeneration

Molecular Formula

– C11H13NNa2O7S2

References

– [1]Kuroda S, et al. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab, 1999, 19(7), 778-787.|[2]Marshall JW, et al. NXY-059, a free radical–trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species. Stroke, 2001, 32(1), 190-198.|[3]Culot M, et al. Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study. Brain Res, 2009, 19(1294), 144-152.

CAS Number

– 168021-79-2

Molecular Weight

– 381.33

Compound Purity

– 98.0

SMILES

– O=S(C1=C(C=CC(S(=O)(O[Na])=O)=C1)/C=[N+]([O-])/C(C)(C)C)(O[Na])=O

Clinical Information

– Phase 3

Research Area

– Neurological Disease

Solubility

– DMSO : 125 mg/mL (ultrasonic)|H2O : ≥ 50 mg/mL

Target

– Reactive Oxygen Species

Pathway

– Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB

Product type

– Reference compound

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=